XML 79 R67.htm IDEA: XBRL DOCUMENT v3.5.0.2
Segment Reporting (Details)
$ in Millions
3 Months Ended 9 Months Ended
May 31, 2016
USD ($)
May 31, 2015
USD ($)
May 31, 2016
USD ($)
Segment
May 31, 2015
USD ($)
Dec. 31, 2014
Segment Reporting [Abstract]          
Number of reportable segments | Segment     3    
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales $ 29,498 $ 28,795 $ 88,715 $ 74,922  
Operating Income 1,533 1,401 4,861 3,832  
Increase in fair market value of AmerisourceBergen warrants       (123)  
Acquisition-related amortization 100 96 282 402  
LIFO provision 93 69 191 176  
Cost transformation 73 160 207 160  
Acquisition-related costs 15 4 82 87  
Asset impairment     30 110  
Store closures and other optimization costs   7   51  
Loss on sale of business   12   12  
Adjusted Operating Income $ 1,814 1,749 $ 5,653 4,707  
Alliance Boots [Member]          
Segment Reporting Information [Line Items]          
Equity interest in Alliance Boots 45.00%   45.00%   45.00%
Walgreens Boots Alliance [Member]          
Segment Reporting Information [Line Items]          
Ownership percentage of WBA         55.00%
Retail Pharmacy USA [Member]          
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales $ 21,185 20,425 $ 63,055 61,027  
Adjusted Operating Income 1,382 1,328 4,257 4,044  
Retail Pharmacy International [Member]          
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales 3,194 3,268 10,414 5,315  
Adjusted Operating Income 258 249 908 374  
Pharmaceutical Wholesale [Member]          
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales 5,748 5,708 17,171 9,573  
Adjusted Operating Income 179 171 500 292  
Eliminations and Unallocated Items [Member]          
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales (629) (606) (1,925) (993)  
Adjusted Operating Income (5) 1 (12) (3)  
Reportable Segments [Member]          
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales 29,498 28,795 88,715 74,922  
Adjusted Operating Income 1,814 1,749 5,653 4,707  
Reportable Segments [Member] | Retail Pharmacy USA [Member]          
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales 21,185 20,425 63,055 61,027  
Adjusted Operating Income 1,382 1,328 4,257 4,044  
Reportable Segments [Member] | Retail Pharmacy International [Member]          
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales 3,132 3,231 10,218 5,248  
Adjusted Operating Income 258 249 908 374  
Reportable Segments [Member] | Pharmaceutical Wholesale [Member]          
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales 5,181 5,139 15,442 8,647  
Adjusted Operating Income 179 171 500 292  
Reportable Segments [Member] | Eliminations and Unallocated Items [Member]          
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales 0 0 0 0  
Intersegment Eliminations [Member]          
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales 0 0 0 0  
Intersegment Eliminations [Member] | Retail Pharmacy USA [Member]          
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales 0 0 0 0  
Intersegment Eliminations [Member] | Retail Pharmacy International [Member]          
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales 62 37 196 67  
Intersegment Eliminations [Member] | Pharmaceutical Wholesale [Member]          
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales 567 569 1,729 926  
Intersegment Eliminations [Member] | Eliminations and Unallocated Items [Member]          
Segment Reporting Information, Operating Income (Loss) [Abstract]          
Sales $ (629) $ (606) $ (1,925) $ (993)